Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Veterinary
Safety Information
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Our Role
Veterinary Medicines Information
Safety Information
How We Monitor Safety
Adverse Reaction/Event Reporting
Information on pharmacovigilance for marketing authorisation holders and applicants
Annual Pharmacovigilance Reports
Pharmacovigilance inspections
Safety Notices
Regulatory Information
Special Topics
Contact details
Veterinary News & Events
Scientific Animal Protection
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Safety Advisory Notice on Barium selenate injectable
Notice type:
Advisory
Date:
13/06/2014
Product name or type:
BVP Barium Selenate Injection 50, VPA 10956/008/002 & BVP Barium Selenate Injection 100, VPA 10956/008/003. Selenate Long Acting 50 mg/ml suspension, VPA 10960/073/001
Authorisation Number:
VPA 10956/008/002, 10956/008/003 & 10960/073/001
Product Classification:
Prescription-only medicine
Authorisation Holder:
BVP Animal Care, Cross Vetpharm Group
Target Audience:
Veterinary Practitioners and distributors of veterinary medicines
Problem Or Issue:
Further to a binding decision of the European Commission on 28 March 2014 that the marketing authorisation of all long acting formulations containing barium selenate for injection that are indicated for all food producing species be suspended on the basis that the benefit-risk balance is negative, the marketing authorisations of all products containing the substance in Ireland have been suspended.
Please be advised that no new batches of these products will be available in Ireland, until the suspension has been lifted.
Background Information Or Related Documents:
Safety Advisory Notice on Barium selenate injectables Document
The decision of the European Commission is attached
http://ec.europa.eu/health/documents/community-register/html/vo24894.htm
The decision follows the outcome of a referral procedure to the European Medicines Agency which led to a scientific evaluation of injectable barium selenate veterinary medicines marketed in the EU which was conducted by the Committee for Medicinal Products for Veterinary Use
http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2013/04/WC500142028.pdf
« Back
Date Printed: 28/03/2024